CoverageForm 410-K10-Q8-K13D13G13F

BKD · Brookdale Senior Living Inc. - Financials

Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.

Price · BKD

Income Statement

Line itemQ1 '26Q4 '25Q3 '25Q2 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23
Revenue$764.86M-$813.16M$812.94M$813.86M-$784.17M$777.54M$782.83M-
Cost of Revenue----------
Gross Profit$216.36M-$210.85M$215.92M$223.09M-$198.12M$204.82M$204.31M-
R&D----------
SG&A$45.06M-$50.87M$54.97M$47.87M-$44.93M$46.66M$45.73M-
Total Operating Expenses$511.47M-$548.28M$562.32M$542.55M-----
D&A$76.95M-$94.79M$92.85M$94.61M-$90.06M$88.03M$88.38M-
Operating Income$51.78M-($53.84M)$14.91M$29.58M-$10.26M$19.16M$19.25M-
Interest Expense--$63.57M$61.57M$57.69M-----
Income Tax($429.0K)-$167.0K($271.0K)($676.0K)-$677.0K$449.0K($40.0K)-
Net Income($6.89M)-($114.73M)($43.02M)($64.98M)-($50.72M)($37.73M)($29.57M)-
EPS - Basic($0.03)-($0.48)($0.18)($0.28)-($0.22)($0.17)($0.13)-
EPS - Diluted($0.03)-($0.48)($0.18)($0.28)-($0.22)($0.17)($0.13)-

Balance Sheet

Line itemQ1 '26Q4 '25Q3 '25Q2 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23
Cash & Equivalents$265.20M$279.12M$253.45M$251.89M$239.73M$308.93M$254.71M$290.02M$318.55M$277.97M
Accounts Receivable$64.36M$67.68M$67.56M$56.06M$57.89M$51.89M$53.00M$49.78M$49.65M$48.39M
Inventory----------
Accounts Payable$84.33M$75.10M$84.77M$83.48M$73.17M$65.52M$73.28M$74.70M$74.50M$66.53M
Current Assets$552.55M$553.94M$536.94M$467.48M$454.03M$512.94M$473.72M$492.83M$515.74M$478.37M
Total Assets$5.90B$5.95B$6.01B$6.14B$6.21B$6.34B$5.94B$5.45B$5.54B$5.57B
Current Liabilities$534.57M$567.92M$637.77M$565.72M$555.71M$579.76M$583.98M$622.09M$614.25M$600.12M
Long-term Debt$4.22B$4.22B$4.16B$4.23B$4.25B$4.02B$3.65B$3.68B$3.69B$3.66B
Total Liabilities$5.95B$6.00B$6.02B$6.03B$6.06B$6.12B$5.64B$5.11B$5.17B$5.17B
Stockholders' Equity($55.94M)($44.75M)($6.73M)$105.38M$146.72M$212.47M$292.88M$340.21M$373.97M$403.66M
Retained Earnings($4.31B)($4.30B)($4.26B)($4.15B)($4.10B)($4.04B)($3.96B)($3.91B)($3.87B)($3.84B)

Cash Flow

Line itemQ1 '26Q4 '25Q3 '25Q2 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23
Operating Cash Flow$20.89M---$23.40M---($1.15M)-
Investing Cash Flow($29.73M)---($326.75M)---($6.95M)-
Financing Cash Flow($508.0K)---$239.67M---$54.09M-
CapEx$46.48M---$41.82M---$44.40M-
Free Cash Flow($25.59M)---($18.41M)---($45.55M)-

Ratios

MetricQ1 '26Q4 '25Q3 '25Q2 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23
Profitability
Gross margin28.3%-25.9%26.6%27.4%-25.3%26.3%26.1%-
Operating margin6.8%--6.6%1.8%3.6%-1.3%2.5%2.5%-
EBITDA margin16.8%-5.0%13.3%15.3%-12.8%13.8%13.7%-
Net margin-0.9%--14.1%-5.3%-8.0%--6.5%-4.9%-3.8%-
Free cash flow margin-3.3%----2.3%----5.8%-
FCF / Net income3.71---0.28---1.54-
R&D / Revenue----------
SG&A / Revenue5.9%-6.3%6.8%5.9%-5.7%6.0%5.8%-
Effective tax rate----------
Return on assets-0.1%--1.9%-0.7%-1.0%--0.9%-0.7%-0.5%-
Return on equity12.3%-1704.4%-40.8%-44.3%--17.3%-11.1%-7.9%-
Return on invested capital1.0%--1.0%0.3%0.5%-0.2%0.4%0.4%-
Liquidity
Current ratio1.030.980.840.830.820.880.810.790.840.80
Quick ratio1.030.980.840.830.820.880.810.790.840.80
Cash ratio0.500.490.400.450.430.530.440.470.520.46
Leverage
Debt / Equity-75.52-94.18-617.9440.1628.9618.9312.4810.819.879.06
Debt / Assets0.720.710.690.690.680.630.620.670.670.66
Debt / EBITDA32.82-101.5539.2734.21-36.4334.3234.30-
Interest coverage---0.8x0.2x0.5x-----
Equity multiplier-105.44-133.00-893.2958.2842.3029.8220.2816.0214.8213.81
Liabilities / Assets1.011.011.000.980.980.970.950.940.930.93
Efficiency
Asset turnover0.13-0.140.130.13-0.130.140.14-
Inventory turnover----------
Days sales outstanding31d-30d25d26d-25d23d23d-
Days inventory outstanding----------
Days payable outstanding----------
Cash conversion cycle----------
Valuation
P / E----------
P / B---15.5x9.8x-5.3x4.6x4.0x-
P / S4.3x-2.5x2.0x1.8x-2.0x2.0x1.9x-
EV / EBITDA56.1x-144.5x52.1x43.9x-49.3x46.1x45.2x-
Growth
Revenue growth (YoY)-6.0%-3.7%4.6%4.0%-3.5%3.6%3.9%-
Revenue CAGR (3y)0.5%-2.4%5.6%6.3%-6.9%2.4%1.5%-
Revenue CAGR (5y)0.4%-0.1%-1.3%-4.3%--4.9%-7.6%-5.6%-
Gross profit growth (YoY)-3.0%-6.4%5.4%9.2%-7.2%10.3%9.0%-
Operating income growth (YoY)75.1%---22.2%53.7%---53.5%146.0%-
Net income growth (YoY)89.4%--126.2%-14.0%-119.8%--3.9%-736.5%33.6%-
EPS growth (YoY)89.3%--118.2%-5.9%-115.4%-0.0%-750.0%35.0%-
EPS CAGR (3y)----------
EPS CAGR (5y)----------
FCF growth (YoY)-39.0%---59.6%----77.5%-
FCF CAGR (5y)----------
Book value growth (YoY)----69.0%-60.8%-47.4%-40.5%-36.7%-30.7%-30.7%

Sales by segment

From XBRL dimensional facts in the 10-K period ending 2025-12-31.

Business segments

$3.19B total
Assisted Living And Memory Care$2.10B · 65.9%
Independent Living$593.81M · 18.6%
Ccrcs Rental$345.60M · 10.8%
Corporate And All Other$151.35M · 4.7%

Product / service

$3.19B total
Health Care Resident Service$3.04B · 95.3%
Reimbursement Costs Managed Communities$140.50M · 4.4%
Management Service$10.85M · 0.3%

Peer comparison

Same SIC group: Services-Nursing & Personal Care Facilities

CompanyRevenue (last FY)Net marginROE
HCSG$1.84B3.2%11.6%
SNDA$381.14M-18.6%643445.5%
ATIP$753.06M-7.7%33.1%
CMAX---
CLRD---

Comparing Brookdale Senior Living Inc. against the 5 most active filers in the same SIC group.

Dividends

$0.00/share trailing 12 months

Ex-datePer share
Oct 8, 2008$0.2500
Jul 2, 2008$0.2500
Mar 27, 2008$0.2500
Dec 27, 2007$0.5000
Sep 26, 2007$0.5000
Jun 27, 2007$0.5000
Mar 28, 2007$0.4500
Dec 27, 2006$0.4500
Sep 27, 2006$0.4000
Jun 28, 2006$0.3500
Mar 29, 2006$0.3500
Dec 28, 2005$0.2500